Malignant mesothelioma following repeated exposures to cosmetic talc: A case series of 75 patients
Sign Up to like & getrecommendations! Published in 2020 at "American Journal of Industrial Medicine"
DOI: 10.1002/ajim.23106
Abstract: Abstract Background Asbestos is the primary known cause of malignant mesothelioma. Some cosmetic talc products have been shown to contain asbestos. Recently, repeated exposures to cosmetic talc have been implicated as a cause of mesothelioma.… read more here.
Keywords: exposures cosmetic; mesothelioma; cosmetic talc; malignant mesothelioma ... See more keywords
miR‐130A as a diagnostic marker to differentiate malignant mesothelioma from lung adenocarcinoma in pleural effusion cytology
Sign Up to like & getrecommendations! Published in 2017 at "Cancer Cytopathology"
DOI: 10.1002/cncy.21869
Abstract: Malignant pleural mesothelioma is a rare tumor with a dismal prognosis, usually presenting with recurrent effusions. However, the majority of malignant pleural effusions are due to lung adenocarcinoma (AdC). The distinction between these tumors has… read more here.
Keywords: lung adenocarcinoma; mesothelioma; mesothelioma lung; cytology ... See more keywords
Comprehensive epithelial biomarker analysis of malignant mesothelioma: EpCAM positivity is a potential diagnostic pitfall.
Sign Up to like & getrecommendations! Published in 2023 at "Cancer cytopathology"
DOI: 10.1002/cncy.22706
Abstract: BACKGROUND Epithelial cell adhesion molecule (EpCAM) is frequently used to distinguish carcinoma from background mesothelial cells during cytologic examination of body cavity fluids. Previously, the authors identified one malignant mesothelioma case with strong and diffuse… read more here.
Keywords: epcam; epcam positivity; malignant mesothelioma; biomarker ... See more keywords
The role of BRCA1‐associated protein 1 in the diagnosis of malignant mesothelioma in effusion and fine‐needle aspiration cytology
Sign Up to like & getrecommendations! Published in 2019 at "Diagnostic Cytopathology"
DOI: 10.1002/dc.24061
Abstract: Malignant mesothelioma (MM) is a diagnostically challenging entity in cytology specimens due to the lack of architectural context and a cytomorphologic overlap between malignant and reactive mesothelial cells (RMCs). A diagnostic marker with excellent specificity… read more here.
Keywords: associated protein; cytology; brca1 associated; malignant mesothelioma ... See more keywords
Evaluation of DNA/RNA quality from cell block of malignant mesothelioma and lung adenocarcinoma
Sign Up to like & getrecommendations! Published in 2022 at "Diagnostic Cytopathology"
DOI: 10.1002/dc.24960
Abstract: Malignant mesothelioma (MM) is a rare and highly lethal tumor that arises from mesothelial tissue on the surface of the chest and abdominal cavity. Cytological examination of body fluids, including pleural fluid and ascites, is… read more here.
Keywords: lung; cell block; mesothelioma; malignant mesothelioma ... See more keywords
Skin metastasis of malignant mesothelioma
Sign Up to like & getrecommendations! Published in 2021 at "Anais Brasileiros de Dermatologia"
DOI: 10.1016/j.abd.2020.07.020
Abstract: utaneous metastasis of malignant pleural mesothelioma is are. We herein report a case of malignant mesothelioma ith distant cutaneous metastasis. A 78-year-old man, who was working as a welder and as exposed to asbestos, visited… read more here.
Keywords: medicine; skin metastasis; metastasis malignant; mesothelioma ... See more keywords
Statin suppresses Hippo pathway-inactivated malignant mesothelioma cells and blocks the YAP/CD44 growth stimulatory axis.
Sign Up to like & getrecommendations! Published in 2017 at "Cancer letters"
DOI: 10.1016/j.canlet.2016.10.020
Abstract: Malignant mesothelioma (MM) frequently exhibits Hippo signaling pathway inactivation (HPI) mainly due to NF2 and/or LATS2 mutations, which leads to the activation of YAP transcriptional co-activator. Here, we show antitumor effects of statin on MM… read more here.
Keywords: yap cd44; cd44; hippo pathway; malignant mesothelioma ... See more keywords
c-MET Immunohistochemistry For Differentiating Malignant Mesothelioma from Benign Mesothelial Proliferations.
Sign Up to like & getrecommendations! Published in 2020 at "Human pathology"
DOI: 10.1016/j.humpath.2020.08.010
Abstract: The separation of benign from malignant mesothelial proliferations can be a difficult problem for the surgical pathologist. c-MET is a receptor tyrosine kinase that is overexpressed and detectable by immunohistochemistry in many malignancies, including malignant… read more here.
Keywords: immunohistochemistry; mesothelial proliferations; score; benign mesothelial ... See more keywords
Cancer genomics of lung cancer including malignant mesothelioma: A brief overview of current status and future prospects.
Sign Up to like & getrecommendations! Published in 2020 at "Advances in biological regulation"
DOI: 10.1016/j.jbior.2020.100723
Abstract: Cancer as a genetic disease is by now well recognized. Genomic analysis of cancer cells, therefore, has greatly enhanced our ability to identify genetic alterations associated with various cancer types, including both lympho-hematopoietic as well… read more here.
Keywords: role; lung cancer; cancer; genomic analysis ... See more keywords
Malignant cells from pleural fluids in malignant mesothelioma patients reveal novel mutations.
Sign Up to like & getrecommendations! Published in 2018 at "Lung cancer"
DOI: 10.1016/j.lungcan.2018.03.009
Abstract: OBJECTIVES Malignant mesothelioma (MM) is an asbestos related tumour affecting cells of serosal cavities. More than 70% of MM patients develop pleural effusions which contain tumour cells, representing a readily accessible source of malignant cells… read more here.
Keywords: malignant cells; tumour cells; cells pleural; reveal novel ... See more keywords
Genomic changes of chromosomes 8p23.1 and 1q21: Novel mutations in malignant mesothelioma.
Sign Up to like & getrecommendations! Published in 2018 at "Lung cancer"
DOI: 10.1016/j.lungcan.2018.10.012
Abstract: INTRODUCTION Malignant mesothelioma is an aggressive malignancy of the thoracic cavity caused by prior asbestos exposure. In the peritoneum the mesothelioma is an extremely rare condition. In the present preliminary study, high-resolution array-comparative genomic hybridization… read more here.
Keywords: changes chromosomes; mesothelioma; genomic changes; 8p23 1q21 ... See more keywords